Hematospermia is the presence of blood in semen as a side effect of a prostate cancer treatment, most notably prostate brachytherapy. While the presence of blood in semen during ejaculation may distress many men, hematospermia is not harmful. After receiving brachytherapy as a treatment for prostate cancer, doctors will encourage their patients to use condoms for the first several times after treatment. In addition to blood in the sperm, patients may also expel migratory seeds. Hematospermia is also common after the prostate needle biopsy. Men who experience hematospermia and who have not undergone any treatment for prostate cancer, may want to consult a doctor. Hematospermia may be associated infections of the prostate gland, seminal vesicles, or urethra, and is less commonly a symptom of prostate cancer. Men who experience blood in the semen for more than three weeks may want to speak with their doctors about a PSA test or a DRE exam.
|
